Piper Sandler initiated coverage on Benitec Biopharma with a new price target

6/13/24 7:03:16 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Piper Sandler initiated coverage of Benitec Biopharma with a rating of Overweight and set a new price target of $30.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BNTC

Date	Price Target	Rating	Analyst
12/16/2024	$28.00	Buy	H.C. Wainwright
12/13/2024	$30.00	Outperform	Robert W. Baird
10/16/2024	$35.00	Outperform	Oppenheimer
9/12/2024	$17.00	Buy	Guggenheim
7/22/2024	$13.00	Outperform	Leerink Partners
6/13/2024	$30.00	Overweight	Piper Sandler
2/17/2022	$10.00	Buy	HC Wainwright & Co.